Those patients generally present an increase in COVID-19-associated inflammatory markers, such as d-dimer, leukocytes count, neutrophil count, neutrophil-to-lymphocyte (NTL) ratio, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and c-reactive protein (CRP) (Wolff et al., 2020). This evidence concerns the gene GPT and COVID-19.